SCHEMBL14213541

SCHEMBL14213541

CCCOc1nsc(N2CCOCC2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.44
MAPK1 P28482 1/20 0.44
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
AR P10275 3/20 0.36
PIK3CB P42338 3/20 0.36
PIK3CD O00329 2/20 0.36
PIK3CA P42336 2/20 0.36
PIK3CG P48736 1/20 0.36
LMNA P02545 1/20 0.36
PRKDC P78527 1/20 0.35
LRRK2 Q5S007 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
TLR7 Q9NYK1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14213022 0.86 SLC29A1 (0.36) SMN1; SMN2MAPK1NPC1RAB9ALMNA
SCHEMBL14213521 0.85 SLC29A1 (0.38) SMN1; SMN2NPC1RAB9ALMNAKMT2A
SCHEMBL14213023 0.81 ALDH1A1 (0.46) SMN1; SMN2MAPK1NPC1RAB9ALMNA
SCHEMBL4849230 0.81 SMN1; SMN2 (0.40) SMN1; SMN2MAPK1NPC1RAB9AAR
SCHEMBL4859814 0.79 SMN1; SMN2 (0.38) SMN1; SMN2MAPK1NPC1RAB9AAR
SCHEMBL14213056 0.77 TLR7 (0.36) LMNAKMT2AKDM4EALDH1A1GAA
SCHEMBL14213174 0.75 ALDH1A1 (0.31) ALDH1A1TSHR
SCHEMBL14213045 0.72 ALDH1A1 (0.46) SMN1; SMN2MAPK1NPC1RAB9ALMNA
SCHEMBL14213532 0.71 SMN1; SMN2 (0.37) SMN1; SMN2MAPK1NPC1RAB9AAR
SCHEMBL14213053 0.70 ALDH1A1 (0.42) SMN1; SMN2NPC1RAB9ALMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371746-B2 1,2,4-Thiadiazole compounds and pests controlling composition containing the same SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-05-13 US disclosed
US-20070004722-A1 1,2,4-Thiadazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004722-A1 1,2,4-Thiadazole compounds and use thereof CYP4F3, CYP4B1, CYP4X1 SMN1; SMN2 3920/4885MAPK1 948/4885NPC1 3070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.